JP2014547627A
JP6144276B2
(en)
|
2011-12-21 |
2012-11-02 |
Dosing schedule for apolipoprotein preparations
|
NZ624558A
NZ624558B2
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
SG11201402556RA
SG11201402556RA
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
EP12859136.9A
EP2793913B1
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
CA2857968A
CA2857968A1
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
US14/364,764
US20140378376A1
(en)
|
2011-12-21 |
2012-11-02 |
Dosage Regime for Apolipoprotein Formulations
|
ES12859136T
ES2955110T3
(en)
|
2011-12-21 |
2012-11-02 |
Dosing Regimen for Apolipoprotein Formulations
|
CN201280063210.4A
CN104010646A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage Regime For Apolipoprotein Formulations
|
PCT/AU2012/001345
WO2013090978A1
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
CN202110675512.8A
CN113398245A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regimen for apolipoprotein formulations
|
KR1020197019295A
KR20190084334A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
RU2017129700A
RU2776110C2
(en)
|
|
2012-11-02 |
Dosing scheme for apolipoprotein compositions
|
KR1020207009276A
KR20200037879A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
RU2014129505A
RU2014129505A
(en)
|
2011-12-21 |
2012-11-02 |
DOSAGE SCHEME FOR APOLIPOPROTEIN COMPOSITIONS
|
PL12859136.9T
PL2793913T3
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
BR112014014403A
BR112014014403A2
(en)
|
2011-12-21 |
2012-11-02 |
dosage regimen for apolipoprotein formulations
|
DK12859136.9T
DK2793913T3
(en)
|
2011-12-21 |
2012-11-02 |
DOSAGE SCHEDULE FOR APOLYPOPROTEIN FORMULATIONS
|
MX2014006589A
MX2014006589A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations.
|
KR1020147020291A
KR20140107536A
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
AU2012310259A
AU2012310259C1
(en)
|
2011-12-21 |
2012-11-02 |
Dosage regime for apolipoprotein formulations
|
IL233236A
IL233236A0
(en)
|
2011-12-21 |
2014-06-18 |
Dosage regime for apolipoprotein formulations
|
HK15100165.2A
HK1199813A1
(en)
|
2011-12-21 |
2015-01-07 |
Dosage regime for apolipoprotein formulations
|
US15/054,358
US20160175392A1
(en)
|
2011-12-21 |
2016-02-26 |
Dosage regime for apolipoprotein formulations
|
JP2017045676A
JP2017128586A
(en)
|
2011-12-21 |
2017-03-10 |
Dosage regime for apolipoprotein formulations
|